US 10639360
Methods for treating hypophosphatemic disorders
granted A61KA61K2039/505A61K2039/54
Quick answer
US patent 10639360 (Methods for treating hypophosphatemic disorders) held by Ultragenyx Pharmaceutical Inc. expires Mon Apr 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Ultragenyx Pharmaceutical Inc.
- Grant date
- Tue May 05 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 14
- CPC classes
- A61K, A61K2039/505, A61K2039/54, A61K2039/545, A61K39/001132